Daniel Compagno

2PUBLICATIONS
1CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Sep 28, 2021
Unraveling How Tumor-Derived Galectins Contribute to Anti-Cancer Immunity Failure.

Diego José Laderach, Daniel Compagno

|Dec 09, 2020
Combining inhibition of galectin-3 with and before a therapeutic vaccination is critical for the prostate-tumor-free outcome.

Carolina Tiraboschi, Lucas Gentilini, Carla Velazquez

Pageof 1

Frequent Collaborators

1 joint publications

Diego José Laderach